Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/ apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.

التفاصيل البيبلوغرافية
العنوان:	Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/ apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
المؤلفون:	Tao Ren, Jinlu Shan, Yi Qing, Chengyuan Qian, Qing Li, Guoshou Lu, Mengxia Li, Chongyi Li, Yu Peng, Hao Luo, Shiheng Zhang, Weiwei Zhang, Dong Wang, Shu-Feng Zhou
المصدر:	Drug Design, Development & Therapy; 2014, Vol. 8, p2517-2529, 13p
قاعدة البيانات:	Complementary Index

الوصف
تدمد:	11778881
DOI:	10.2147/DDDT.S71432